This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ralph R. Paylor, MD; Gholam A. Peyman, MD
Chicago

Arch Ophthalmol. 1985;103(12):1782-1783.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Silicone oil was initially introduced into clinical ophthalmology to treat complicated retinal detachment by Cibis et al¹ in 1964. By 1967, the adverse effects of silicone oil were thought to be greater than its benefits, and its use subsequently fell into disfavor in the United States.² In the early 1970s, the use of silicone oil was revived in Europe for the repair of complicated retinal detachment. In recent years, the main complications from the use of silicone oil have been cataract formation, late-onset glaucoma, and keratopathy. Of these, keratopathy has been the most difficult to manage, often requiring removal of the silicone oil.³ Histopathologic studies have shown that the adverse effects on the lens and cornea are due to the mechanical obstruction of the flow of nutrients to these tissues by silicone oil.⁴

In patients who have undergone multiple intraocular procedures, who are . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?